Chongqing Huapont Pharmaceutical Co., Ltd. was established in 1994 and is located in Liangjiang New District, Chongqing, China. It is a national high-technology, innovative, and intelligent model manufacturing enterprise. It has a national enterprise technology center and a number of municipal R&D platforms, two FDF factories, two API factories.
For more than 20 years in the past, Huapont people have been regarded "protecting human health with high-quality products" as the corporate vision, and are committed to the research and development, production and customer service of pharmaceutical products. Huapont has deepened into a professional dermatological service provider in China, and has a rich product line in the field of anti-tuberculosis。In addition, Huapont is also widely involved in the fields of breathing, cardiovascular and cerebrovascular, blood, tumor, systemic glucocorticoids, etc. and accumulated a large number of star drugs. In 2021, Huapont has launched first skin care brand “SANRUI” in order to get involved in general dermatology area. The company has obtained more than 160 invention patent authorizations and more than 390 registered trademarks till now, Huapont has been rated as an intellectual property advanced enterprise.
In the future, Huapont will continue to be market-oriented, patient-centric to meet various health needs of customers through technological innovation, high-quality products and professional customer service. We will form an intelligent manufacturing platform for the entire pharmaceutical industry chain inlcude API research and development, formulation research and development, Clinical medical research, digital production and all-channel marketing. At the same time, we will develop non-pharmaceutical product pipelines such as skin care, medical beauty and health, and focus on the research and development of general dermatological product to reach the domestic advanced level in order to work together to accomplish our final duty and mission that “Satisfying clinical, serving the patients, and being faithful to human health!”